@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix owl: . @prefix dc: . @prefix xsd: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R4XW9RSG-V skos:broader jvr:-ZSFBN4K6-W, jvr:-FGZLXJZK-T ; mesh:pharmacologicalAction jvr:-X1H75KMP-P, jvr:-BN87VH98-Z ; owl:sameAs ; mesh:allowableQualifier jvr:-CB30NGKB-3, jvr:-D0F21513-5, jvr:-L6C0XPHT-4, jvr:-WK5F724J-1, jvr:-R3QWLHRG-V, jvr:-S0CS1X5R-5, jvr:-SBNWSM1T-R, jvr:-TJHVZCRZ-0, jvr:-NFTHND7Q-8, jvr:-H7K65Q8S-Z, jvr:-FWD2BGQ0-9, jvr:-M63HSDM7-1, jvr:-R0ZCQ8X6-J, jvr:-Q3979798-W, jvr:-BT300B3G-Q, jvr:-NB0XHT3S-N, jvr:-T9HQD7ST-J, jvr:-NKM836P1-M, jvr:-THHNVC7V-3, jvr:-G30ZJ446-J, jvr:-W6SQV79N-S, jvr:-XV06LPML-W, jvr:-NHL3D2X0-S, jvr:-HQRFT0C6-B, jvr:-G4R176S9-J ; skos:altLabel "HP46XK89XB"@fr, "HP46XK89XB"@en, "10H-Phenothiazine, 2-(ethylthio)-10-(3-(4-methyl-1-piperazinyl)propyl)-"@en, "10H-Phenothiazine, 2-(ethylthio)-10-(3-(4-methyl-1-piperazinyl)propyl)-"@fr, "52239-63-1 (malate (1:2))"@fr, "1179-69-7 (maleate (1:2))"@fr, "1179-69-7 (maleate (1:2))"@en, "52239-63-1 (malate (1:2))"@en, "1420-55-9 (Thiethylperazine)"@fr, "1420-55-9 (Thiethylperazine)"@en, "8ETK1WAF6R"@fr, "8ETK1WAF6R"@en ; skos:prefLabel "Thiethylperazine"@en, "Thiéthylpérazine"@fr ; skos:hiddenLabel "Thiethylperazine Malate"@en, "Thiethylperazine Maleate (2:1)"@en, "Maléate de thiéthylpérazine"@fr, "Torecan"@en, "Malate de thiéthylpérazine"@fr, "Norzine"@en ; dc:established "1965-01-01"^^xsd:date ; skos:inScheme jvr: ; a skos:Concept, mesh:Descriptor ; dc:created "1999-01-01"^^xsd:date ; skos:definition "A dopamine antagonist that is particularly useful in treating the nausea and vomiting associated with anesthesia, mildly emetic cancer chemotherapy agents, radiation therapy, and toxins. This piperazine phenothiazine does not prevent vertigo or motion sickness. (From AMA Drug Evaluations Annual, 1994, p457)"@en ; dc:modified "2018-07-05"^^xsd:date . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-FGZLXJZK-T skos:prefLabel "Phenothiazines"@en, "Phénothiazines"@fr ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-R4XW9RSG-V . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-BN87VH98-Z skos:prefLabel "Antagonistes de la dopamine"@fr, "Dopamine Antagonists"@en ; a mesh:Descriptor, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-X1H75KMP-P skos:prefLabel "Antiemetics"@en, "Antiémétiques"@fr ; a mesh:Descriptor, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-ZSFBN4K6-W skos:prefLabel "Piperazines"@en, "Pipérazines"@fr ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-R4XW9RSG-V . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .